ECG Telemetry Devices Market Size, Share, Growth and Forecast (2026 - 2036)

ECG Telemetry Devices Market Forecast and Outlook By Fact.MR

• The ECG telemetry devices market was valued at USD 3.1 billion in 2025.
• Based on Fact.MR analysis, demand is estimated to grow to USD 3.3 billion in 2026 and USD 7.2 billion by 2036.
• Fact.MR projects an 8.0% CAGR during the forecast period.
• The market is expected to generate USD 3.9 billion in incremental revenue opportunity between 2026 and 2036.
• Market expansion is linked to portable rhythm monitoring and hospital telemetry systems that support faster clinical review.
• Cardiac care teams need devices that track rhythm changes for longer periods.
• High device cost still slows adoption in price-sensitive health systems.

Summary of ECG telemetry devices market

• Demand Drivers
  • Long-term Arrhythmia Testing: Longer rhythm checks are shifting demand from short ECG tests to Holter and event monitors.
  • Hospital Telemetry Upgrades: Hospitals need telemetry systems that connect bedside heart data with central review.
  • Home Healthcare Use: Home care demand supports lighter ECG devices and patches for patients who need rhythm checks outside hospitals.
• Key Segments Analyzed
  • By Product: Resting ECG Devices are projected to account for 42.6% share in 2026 as routine cardiac checks still start with 12-lead ECG testing.
  • By Application: Arrhythmias are projected to account for 46.8% share in 2026 due to repeat rhythm checks for atrial fibrillation and sudden cardiac risk.
  • By End User: Hospitals are projected to hold 52.4% share in 2026 since telemetry beds and emergency units use continuous cardiac monitoring.
  • By Monitoring Mode: Continuous Monitoring is projected to hold 58.2% share in 2026 because high risk patients need constant rhythm review.
  • By Lead Configuration: 12-Lead Systems are projected to account for 47.5% share in 2026 as clinicians use standardized readings for diagnosis.
  • By Sales Channel: Direct Sales are projected to hold 61.3% share in 2026 because hospitals prefer service backed supply agreements.
• Analyst Opinion at Fact.MR
  • Shambhu Nath Jha, Principal Consultant at Fact.MR, opines “ECG telemetry demand is shifting from one-time readings to connected rhythm review. Hospitals need steady signal capture and faster report review. Service support now matters in device selection. Suppliers with reliable electrodes and longer battery life will be better placed. Software links with hospital systems will guide large account choices. Clients should compare total service cost instead of device price alone.”
• Strategic Implications
  • Manufacturers should improve battery life and make Holter and event monitors more comfortable on the skin. Product testing should check signal noise clearly.
  • Suppliers should sell hospital telemetry systems with proper training and clear service support.
  • Companies should build local service teams in China and India so cardiac monitoring teams face less downtime.

China is projected to record the highest country CAGR at 12.0% through 2036 due to domestic hospital upgrades and higher CVD patient volume. India follows at 9.4% as private cardiac chains add long term rhythm testing. The United States grows at 7.3% due to reimbursement depth and replacement of older telemetry monitors. South Korea advances at 7.1% as tertiary hospitals invest in monitored cardiac beds. The United Kingdom rises at 6.6% due to NHS cardiac backlog work and ambulatory rhythm testing. Germany records 5.5% due to clinical proof rules and steady hospital upgrades. Japan expands at 5.0% due to older patient volume and strict device quality demand.

Segmental Analysis

ECG Telemetry Devices Market Analysis by Product

Resting ECG Devices are projected to account for 42.6% share in 2026 as hospitals and clinics use resting 12-lead tests before longer rhythm checks. Good electrode quality and clear signal capture guide purchase decisions. Regular replacement of ECG cable and ECG lead wires supports product demand in diagnostic rooms.

• Resting ECG Demand: Clinical teams use resting ECG devices as the first test before Holter or event monitoring.
• Holter Monitor Growth: Longer rhythm checks support higher use in arrhythmia testing and post-discharge follow-up.

ECG Telemetry Devices Market Analysis by Application

Arrhythmias are projected to account for 46.8% share in 2026 due to repeat testing needs for atrial fibrillation and sudden cardiac risk. Longer rhythm recording helps clinicians detect events missed during a short ECG. Use of single-lead ECG monitors is rising in low acuity follow-up and early rhythm screening.

• Arrhythmia Review: Clinics use telemetry data to confirm rhythm events before treatment decisions.
• Ischemia Testing: Stress ECG units support exercise-based assessment in cardiology labs.

ECG Telemetry Devices Market Analysis by End User

Hospitals are projected to hold 52.4% share in 2026 as emergency units and cardiac wards need continuous patient review. Hospital teams check signal accuracy and alarm reliability before purchase. Service speed and software connection quality shape final selection. Home healthcare is growing from a smaller base as clinicians move selected rhythm checks to ambulatory care.

• Hospital Demand: Tertiary hospitals need bedside telemetry and central review stations for high-risk patients.
• Home Care Growth: Home-based rhythm checks support patients who need longer monitoring after discharge.

ECG Telemetry Devices Market Analysis by Monitoring Mode

Continuous Monitoring is projected to hold 58.2% share in 2026 as cardiac wards need constant rhythm review and alarm checks. This mode supports high risk patients after chest pain visits and procedures. Pacemaker follow up may need the same rhythm review. Demand for remote patient monitoring devices supports use outside hospitals for selected patients.
• Continuous Monitoring Demand: Cardiac units use constant rhythm review for patients with unstable symptoms.
• Intermittent Monitoring Use: Lower risk patients use shorter review periods to control device cost.

ECG Telemetry Devices Market Analysis by Lead Configuration

12-Lead Systems are projected to account for 47.5% share in 2026 as clinicians use standard waveform views for diagnosis. Multi-lead checks help detect ischemia signs and rhythm issues with better confidence. Interest in non-contact ECG sensors is still early but can support cases that need less skin contact.
• 12-Lead Preference: Hospitals use 12-lead systems for routine diagnosis and preoperative checks.
• Single-Lead Use: Single-lead devices support lighter ambulatory monitoring in lower acuity cases.

ECG Telemetry Devices Market Analysis by Sales Channel

Direct Sales are projected to hold 61.3% share in 2026 as hospital groups prefer direct supply terms with training and service support. Large accounts often need integration checks and replacement planning before approval. Distributor sales serve smaller clinics and home care equipment providers.
• Direct Sales Strength: Hospital groups prefer vendor accountability for service and staff training.
• Distributor Role: Small clinics use distributors for faster access to standard ECG devices.

Drivers, Restraints and Opportunities

The ECG telemetry devices market expands as hospitals manage higher cardiac disease burden and need faster rhythm review. Telemetry systems help care teams record longer rhythm changes beyond a standard ECG check.

Demand is driven by arrhythmia testing and hospital monitoring needs rather than a single device upgrade cycle. WHO reported 19.8 million deaths from CVDs in 2022. This disease load keeps health systems focused on earlier rhythm detection and better follow up for at risk patients. [1]

Device cost remains a restraint because portable ECG telemetry systems require sensors and transmitters. Software and service support raise total ownership cost for smaller hospitals and clinics. Cardiac patch monitors create opportunity by capturing longer rhythm data with less patient burden.

• Long Rhythm Monitoring Demand: Arrhythmia detection requires longer recording windows than a standard ECG check can provide.
• Cost Pressure in Budget-Limited Care: High device price and service cost slow replacement across smaller hospitals and public tenders.
• Home Care Monitoring Opportunity: Home care programs create demand for lighter ECG telemetry devices and cloud based ECG review.

Regional Analysis

The ECG telemetry devices market is assessed across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The full report covers country demand by product and application. It also covers end user, monitoring mode, lead configuration, and sales channel.

Source: Fact.MR analysis, based on proprietary forecasting model and primary research

Asia Pacific ECG Telemetry Devices Market Analysis

Asia Pacific shows the fastest country-level gains in ECG telemetry devices. China and India are expanding cardiac care capacity and local service support. Large hospital systems are using more telemetry devices for rhythm review and patient monitoring.

• China: China is projected to record 12.0% CAGR through 2036. Hospital upgrades and high CVD patient volume support demand for ECG telemetry systems. The 2025 China cardiovascular health report estimated 330 million people with CVD. Large hospitals need systems that can handle rising cardiac testing volume. [3]
• India: India is likely to expand at 9.4% CAGR through 2036. Private cardiac chains are adding ambulatory ECG access and long-term rhythm testing. Adult CVD prevalence is measured at 11.0%. This supports demand for Holter monitors and event monitors outside crowded hospital departments. [6]
• Japan: Japan is forecast to post 5.0% CAGR through 2036. Older patient volume supports steady replacement demand for ECG telemetry devices. Heart failure accounts for 1% to 2% of all hospitalizations in Japan. Device approval rules keep demand focused on clinically proven systems. [5]
• South Korea: South Korea is projected to advance at 7.1% CAGR through 2036. Tertiary hospitals are adding monitored cardiac care capacity. In 2023, 33,586 out-of-hospital cardiac arrest cases were transported by 119 emergency medical services. This supports faster rhythm review in emergency care. [8]

North America ECG Telemetry Devices Market Analysis

North America holds a large revenue base for ECG telemetry devices. Reimbursement support and hospital replacement cycles keep demand steady. Outpatient rhythm testing centers create more demand for portable monitoring devices.

• United States: The United States is forecast to grow at 7.3% CAGR through 2036. CVD caused 919,032 deaths in 2023. This burden supports telemetry demand in emergency rooms and cardiac units. Hospitals continue to focus on clinical accuracy and fast service response. [2]

Europe ECG Telemetry Devices Market Analysis

Europe shows steady demand as national health systems manage cardiac care backlogs. Hospital replacement needs support ECG telemetry device use. Data security and clinical proof guide product selection.

• Germany: Germany is forecast to grow at 5.5% CAGR through 2036. Robert Koch Institute recorded 119,795 deaths from coronary heart disease in 2023. German hospitals value proven clinical performance and data security. These needs support suppliers with trained service teams. [7]
• United Kingdom: The United Kingdom is projected to rise at 6.6% CAGR through 2036. NHS cardiac care pressure supports demand for ambulatory rhythm testing. More than 8 million people live with CVD in the United Kingdom. Compact ECG telemetry systems can help clinicians reduce repeat visits for selected patients. [4]

Competitive Aligners for Market Players

ECG telemetry suppliers compete on signal quality and report speed. Service reach and hospital software connection shape account selection. GE HealthCare and Philips have large hospital portfolios. Nihon Kohden and Mindray have strong patient monitoring systems. Specialized firms such as iRhythm and AliveCor support ambulatory rhythm review. ECG telemetry devices favor suppliers that can prove reliability in hospitals and home care.

Large medical device firms benefit from installed hospital systems and trained service teams. Their strength comes from central monitoring platforms and replacement contracts. Smaller firms can compete in ambulatory care with better patient comfort and faster report turnaround.

Purchase teams compare electrode quality and battery life. Alarm accuracy and software security guide final approval. Total service cost is checked before orders are signed. Hospitals often avoid low price devices if they cause repeat tests or downtime. Suppliers with local repair and training teams can protect their hospital accounts.

China and India create room for local production and country-level service expansion. Price matters in public hospital tenders and mid-sized private hospitals. Premium suppliers can still win critical care orders through clinical proof and steady service support.

Key Players

• GE HealthCare
• Koninklijke Philips N.V.
• Nihon Kohden Corporation
• Medtronic plc
• Baxter International Inc.
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• iRhythm Technologies Inc.
• AliveCor Inc.

Bibliography

• [1] World Health Organization. (2025, July 31). Cardiovascular diseases (CVDs).
• [2] Centers for Disease Control and Prevention. (2024, October 24). Heart disease facts.
• [3] Su, S., & Liu, F. (2025). Cardiovascular health and disease report in China: Two decades of progress. Biomedical and Environmental Sciences, 38(8), 891–892.
• [4] British Heart Foundation. (2026, January). UK cardiovascular disease factsheet.
• [5] Asia-Pacific Cardiovascular Disease Alliance. (2024, August). A call for cohesive action: Redefining cardiovascular care in the Asia-Pacific: Country report Japan.
• [6] Shannawaz, M., Rathi, I., Shah, N., Saeed, S., Chandra, A., & Singh, H. (2025). Prevalence of CVD among Indian adult population: Systematic review and meta-analysis. International Journal of Environmental Research and Public Health, 22(4), Article 539. https://doi.org/10.3390/ijerph22040539
• [7] Robert Koch Institute. (2025, December 17). Coronary heart disease: Mortality.
• [8] Kim, J., Lee, J., & Jeon, E. (2024). Incidence of out-of-hospital sudden cardiac arrest in the Republic of Korea, 2023. Public Health Weekly Report, 17(49), 2211–2223.

This Report Addresses

• Strategic demand analysis for ECG telemetry devices across hospitals, clinics, home healthcare, cardiac units, emergency departments, and ambulatory rhythm monitoring applications globally.
• Market forecast from USD 3.3 billion in 2026 to USD 7.2 billion by 2036 at 8.0% CAGR, with segment-level analysis by product, application, end user, monitoring mode, lead configuration, and sales channel.
• Opportunity mapping across China, India, the United States, South Korea, the United Kingdom, Germany, and Japan based on cardiac disease burden, hospital upgrades, and ambulatory ECG testing growth.
• Segment analysis by product, application, end user, monitoring mode, lead configuration, and sales channel with regional and country-level forecasts through 2036.
• Competitive analysis of GE HealthCare, Koninklijke Philips N.V., Nihon Kohden Corporation, Medtronic plc, Baxter International Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., iRhythm Technologies Inc., and AliveCor Inc.
• Clinical demand analysis covering arrhythmia testing, myocardial ischemia and infarction review, pacemaker monitoring, continuous monitoring, and intermittent monitoring requirements.
• Report delivery in PDF, Excel, and presentation formats supported by clinical data, regulatory source material, product portfolio review, and hospital demand interviews.

ECG Telemetry Devices Market Definition

The ECG telemetry devices market covers equipment that records and transmits heart electrical signals for clinical review. Included products span resting ECG systems and stress ECG units. Holter monitors and event monitors are included. Telemetry transmitters and ECG data stations are included. These systems support arrhythmia testing and ischemia review. They support pacemaker follow up and monitored care in hospitals or home settings.

ECG Telemetry Devices Market Inclusions

The study includes global and regional forecasts from 2026 to 2036 by product and application. It covers end user and monitoring mode. Lead configuration and sales channel are covered across hospital and home care settings.

ECG Telemetry Devices Market Exclusions

The study excludes implantable pacemakers and cardiac ablation systems. Consumer wellness watches without clinical ECG claims are outside scope. Hospital network hardware sold apart from ECG telemetry use is outside scope.

ECG Telemetry Devices Market Research Methodology

• Primary Research
  • Interviews covered hospital biomedical teams and cardiology department heads. Distributors and product managers were consulted across the United States and China. Inputs covered India and Germany. Japan and South Korea were reviewed through supplier and clinical demand checks. Inputs focused on device replacement cycles and channel margins. Service needs and buying criteria for telemetry systems were reviewed.
• Desk Research
  • Desk research reviewed public clinical data and regulator records. Product catalogs and patent filings were checked. Company portfolio pages were reviewed for active product coverage. Fact.MR used the uploaded ECG telemetry source as the base market anchor and updated the forecast window to 2026 through 2036.
• Market-Sizing and Forecasting
  • The model combines equipment replacement and hospital telemetry bed demand. It adds ambulatory rhythm testing volume and average selling prices by product class. Country estimates were adjusted for cardiac care access and reimbursement depth. Supplier service coverage was used as a final check.
• Data Validation and Update Cycle
  • Forecasts were checked against CVD burden data and regulatory source material. Active supplier portfolios were reviewed before finalization. Fact.MR updates the model each year as device clearances and hospital purchase cycles change. Public health data is reviewed during each update.